<!--
;;;***************************************************************************
;;;* Copyright 2017 by Cancer Commons                                        *
;;;*                                                                         *
;;;* Permission is hereby granted, free of charge, to any person obtaining   *
;;;* a copy of this software and associated documentation files (the         *
;;;* "Software"), to deal in the Software without restriction, including     *
;;;* without limitation the rights to use, copy, modify, merge, publish,     *
;;;* distribute, sublicense, and/or sell copies of the Software, and to      *
;;;* permit persons to whom the Software is furnished to do so, subject to   *
;;;* the following conditions:                                               *
;;;*                                                                         *
;;;* The above copyright notice and this permission notice shall be          *
;;;* included in all copies or substantial portions of the Software.         *
;;;*                                                                         *
;;;* THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND,         *
;;;* EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF      *
;;;* MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND                   *
;;;* NONINFRINGEMENT. IN NO EVENT SHALL THE AUTHORS OR COPYRIGHT HOLDERS BE  *
;;;* LIABLE FOR ANY CLAIM, DAMAGES OR OTHER LIABILITY, WHETHER IN AN ACTION  *
;;;* OF CONTRACT, TORT OR OTHERWISE, ARISING FROM, OUT OF OR IN CONNECTION   *
;;;* WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE SOFTWARE.         *
;;;***************************************************************************
-->

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">EGFR expression confers sensitivity to temozolomide in GBM.</textarea><br>
  <input type="submit" value="Parse">
</form>

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">In GBM, EGFR expression confers sensitivity to temozolomide.</textarea><br>
  <input type="submit" value="Parse">
</form>

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">In a randomized controlled trial involving 100 patients with stage 2 metastatic lung cancer (shrager, 1998), EGFR expression confers sensitivity to dexamethasone.</textarea><br>
  <input type="submit" value="Parse">
</form>

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">EGFR expression shows resistance to temozolomide in this elderly man.</textarea><br>
  <input type="submit" value="Parse">
</form>

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">NRAS expression conferred resistance to ipilimumab in a 50 year old man with lung cancer.</textarea><br>
  <input type="submit" value="Parse">
</form>

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">EGFR expression confers sensitivity to paclitaxel in metastatic breast cancer.</textarea><br>
  <input type="submit" value="Parse">
</form>

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">In a randomized controlled trial with 200 patients with stage 2 metastatic melanoma, EGFR expression leads to resistance to cisplatin.</textarea><br>
  <input type="submit" value="Parse">
</form>

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">Keppra induces fatigue and wobbliness</textarea><br>
  <input type="submit" value="Parse">
</form>

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">TMZ lead to toxicity in a clinical trial of 30 patients with GBM.</textarea><br>
  <input type="submit" value="Parse">
</form>

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">Sorafenib significantly accelerated disease progression in a phase II clinical trial of 11 patients with PLGA.</textarea><br>
  <input type="submit" value="Parse">
</form>

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">EGFR expression shows resistance to temozolomide in this elderly man.</textarea><br>
  <input type="submit" value="Parse">
</form>

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">EGFR deletion confers resistance to cisplatin in lung cancer.</textarea><br>
  <input type="submit" value="Parse">
</form>

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">Radiotherapy caused major toxicity in a trial of 117 patients with brain cancer.</textarea><br>
  <input type="submit" value="Parse">
</form>

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">In lung cancer, egfr deletion confers sensitivity tmz and cisplatin.</textarea><br>
  <input type="submit" value="Parse">
</form>

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">EGFR deletion confers sensitivity tmz and cisplatin in lung cancer.</textarea><br>
  <input type="submit" value="Parse">
</form>

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">EGFR deletion confers sensitivity tmz and cisplatin.</textarea><br>
  <input type="submit" value="Parse">
</form>

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">EGFR expression confers sensitivity tmz and cisplatin.</textarea><br>
  <input type="submit" value="Parse">
</form>

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">BRAF expression confers sensitivity tmz and cisplatin.</textarea><br>
  <input type="submit" value="Parse">
</form>

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">EGFR deletion and braf expression confers sensitivity tmz and cisplatin.</textarea><br>
  <input type="submit" value="Parse">
</form>

<form action="http://platformtest.cancercommons.org:4242/cnlparser" id="myform">
  Text:<br>
  <textarea rows=3 cols=120 name="s">In a ranomized controled trial invoving 100 patents with stage 2 metstatic lugn cacner (shrager, 1998), EGFR experssion confers sensiitvity to dexmaethsaon.</textarea><br>
  <input type="submit" value="Parse">
</form>
